Novelion Therapeutics Inc (NASDAQ:NVLN)

4.28
Delayed Data
As of Feb 23
 +0.11 / +2.64%
Today’s Change
3.08
Today|||52-Week Range
12.12
+37.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Stern Donald K
Director
Buy6/12/20172,500$9.10$22.8K-50.97%
Szela Mary J
Chief Executive Officer
Sale5/09/20172,248$9.42$21.2K-54.56%
Perry Gregory D
Corporate Officer
Sale5/09/2017710$9.42$6.7K-54.56%
Aryeh Jason M
Director
Buy5/15/2017361$8.95$3.2K-52.29%
Harshbarger Benjamin J
General Counsel
Sale5/15/2017232$8.97$2.1K-52.29%
Louis Roger W
Corporate Officer
Sale5/09/2017162$9.42$1.5K-54.56%
Harshbarger Benjamin J
General Counsel
Sale5/09/2017121$9.42$1.1K-54.56%
Harshbarger Benjamin J
General Counsel
Sale5/09/2017113$9.42$1.1K-54.56%
Buono Linda
Senior Vice President-Human Resources
Sale5/09/201793$9.42$876.06-54.56%
Harshbarger Benjamin J
General Counsel
Sale9/17/2017109$7.08$771.72-38.94%
Page of 3